๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

CXCL13 as a Novel Marker for Diagnosis and Disease Monitoring in Pediatric PTLD

โœ Scribed by L. Schiffer; C. Henke-Gendo; N. Wilsdorf; K. Hussein; L. Pape; C. Schmitt; H. Haller; M. Schiffer; C. Klein; H. Kreipe; B. Maecker-Kolhoff


Book ID
114806365
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
506 KB
Volume
12
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Detection of HEV antigen as a novel mark
โœ Feng Zhang; Xiuhua Li; Zhuo Li; Tim J. Harrison; Huihui Chong; Shan Qiao; Weijin ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 260 KB

Infection with hepatitis E virus (HEV) may be diagnosed by the presence of HEV RNA or anti-HEV antibodies. An enzyme immunoassay (EIA) was developed for the detection of antigen. Twenty-four monoclonal antibodies (mAbs) were produced. An indirect sandwich EIA was developed to detect HEV antigen usin

Serum ฮฑ1-antitrypsin levels as a marker
โœ Dr. Michael J. Pettei; Jeremiah J. Levine ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 465 KB

The purpose of this study was to evaluate the use of the acute-phase serum protein a,-antitrypsin (a,- AT) compared with the erythrocyte sedimentation rate (ESR), platelet count, and hemoglobin level in screening for inflammation in newly diagnosed and known patients with inflammatory bowel disease